Slashdot Mirror


New Alzheimer's Drug Shows Promise

An anonymous reader writes "The Herald Sun is reporting that researchers may have some progress to report on the Alzheimer's front. A new drug, called PBT2, was developed by a Melbourne-based biotech firm that has been showing some promising results. From the article: 'Early clinical testing has confirmed the drug is fast-acting. Levels of amyloid dropped by 60 per cent within 24 hours of a single dose. It found also that PBT2 suppresses the impairment of memory function. More human studies begin in Sweden next month and Australians will join a major international trial of the drug next year.'"

10 of 82 comments (clear)

  1. Heh by Anonymous Coward · · Score: 4, Funny

    "The Herald Sun is reporting that researchers may have some progress to report on the Alzheimer's front. Maybe. They can't exactly remember one way or the other..."

  2. catch-22 by macadamia_harold · · Score: 5, Funny

    The Herald Sun is reporting that researchers may have some progress to report on the Alzheimer's front. A new drug, called PBT2, was developed by a Melbourne-based biotech firm that has been showing some promising results.

    Fantastic. Now they just have to remember to take it.

  3. animal data not clinical trials? by simong_oz · · Score: 5, Informative

    From the article: 'Early clinical testing has confirmed the drug is fast-acting. Levels of amyloid dropped by 60 per cent within 24 hours of a single dose. It found also that PBT2 suppresses the impairment of memory function.

    The article seems to be wrong - press releases on the Prana Biotechnology website indicate these results are from studies in mice.

    More human studies begin in Sweden next month and Australians will join a major international trial of the drug next year.

    If the data is from mice, then the above clinical trial is presumably a phase I clinical trial, which is designed to show safety and not efficacy. It could be a while before human data is available.

    Of course, none of this will stop investors believing the article ;-)

    --
    "Because it's there." - George Mallory, when asked why he wanted to climb Mt Everest, March 18, 1923 (New York Times)
    1. Re:animal data not clinical trials? by Unc-70 · · Score: 4, Interesting

      On the other hand if you take a look at the pdf linked on the homepage (pdf warning), you will see that it is a clinical trial designed to assess both safety and efficacy. It's pretty small numbers though (18 completers) and the efficacy is assesed by cognition tests. There's certainly no mention of amyloid reduction so that may well refer to the animal studies.

      --
      Ye have made your way from the worm to man, and much within you is still worm.
  4. Major news for nursing homes by Nocterro · · Score: 5, Insightful

    If this drug is found to actually work, and proceeds to be available for general use within the next five years, it would be a major reversal of the trends we're seeing at the moment. I work in a nursing home designed and built in the 70's, when nursing homes tended to be the place you stayed briefly before dying. Now with our medical advances, together with the high level of day to day care, individually tailored diets etc, we're dealing with people who are living longer. This means we're now running into problems with alzheimers, excarberated by the cocktail of drugs administered. Effectively we're now running into trouble trying to keep people with high level dementia in unsuited facillities. The possibility of an effective treatment for alzheimers makes me wonder if we might be going to move back to the older situation, with lives limited by health again.

    --
    [clever sig]
    1. Re:Major news for nursing homes by montyzooooma · · Score: 4, Informative
      I was going to write that I didn't think Alzheimer's affected that big a proportion of the elderly but then I actually googled the numbers and apparently it affects 10% of the over 65s and 50% of the over 85s (found here: http://www.alz.org/maintainyourbrain/overview.asp )

      Those are actually pretty serious numbers and far higher than I thought.

    2. Re:Major news for nursing homes by Psmylie · · Score: 4, Insightful
      My father-in-law had this disease in the last few years of his life, and it was pretty horrible. I have no intention to slam nursing homes (you guys have one hell of a hard job to do) but most of them are just not set up to deal with Alzheimer's or dementia. Many we talked refused to admit patients with Alzheimer's, since the confusion and fear the disease causes can lead to anger and violence. I understand and sympathize with nursing home staff. But, when we were dealing with my father-in-law, it became very clear to me that we needed actual Alzheimer's wards where they could specialize in their care.


      For the most part (at least where I live) patients with Alzheimer's got shipped off to mental wards. That's where my father-in-law ended up for a while, before he became vegetative. He was convinced that he was in jail for something, and got angry because nobody would tell him why. He kept trying to get out, and pushed the orderlies when they tried to stop him. They ended up placing him in leather restraints (which, I understand, is NOT something they're supposed to do, especially long-term). We went to visit him one day and found him locked in a sweltering room with no air-conditioning or fans, strapped to a table, wearing nothing but an adult diaper, and screaming in rage and terror, because he didn't know why he was locked up.

      I used to make Alzheimer's jokes, before I actually knew someone who had it. I feel bad about that now. This is a terrible disease. I'll throw a huge party the day they actually come up with a cure for it.

      --

      psmylie's dictionary: Godzillion (noun) Any number large enough to destroy Tokyo

  5. More info by Cicero382 · · Score: 5, Insightful

    It's interesting but not (yet) as significant as TFA makes out.

    These are studies on transgenic mice, so it's more a proof-of-concept rather than clinical trials which will be some way off - mostly due to bureaucracy.

    For those who want a quick *scientific-ish* summary:

    It is widely believed that a protein called Beta-Amyloid is reponsible synaptic dysfunction in Altzheimer's disease. Another variant (Alpha-Amyloid) also does horrible things to the body such as renal failure and constrictive pericarditis. This often happens as a result of certain auto-immune diseases (which is my speciality).

    These tests are based on the accidental discovery that a dysentry drug (PBT-1) has some effects on restoring some cognitive function in patients. The company pursuing this has created a drug which is more specifically targeted towards reducing levels of A-A. And... so far, so good. The mice show greatly reduced A-A levels and they perform better in mazes. I wish them all the best - Altzheimers is a horrible and frightening disease.

    For those who would like a fuller summary in non newspaper-speak, try http://www.medicalnewstoday.com/medicalnews.php?ne wsid=47696

  6. This is interesting news by Anonymous Coward · · Score: 5, Insightful

    Living through your parent's early onset (at 50 years) Alzheimer's really takes egde off any humour of this story. Personally, I welcome these news, there are too few of them. Unfortunately, this drug would come too late for my father, who has now been living with this for 15 years (he really takes his time to do things properly, even dying). New drugs would also offer some hope for relatives, since A is also hereditary to at least some extent.

  7. victory is at hand! by pchan- · · Score: 4, Funny

    Brothers, our time has come. This is the secret weapon that will allow our final victory over The Old People! With this technology in our hands, they will be our slaves. They will mine our ore and harvest our lumber to have access to our precious Alzheimers medicine. The Groundor has become the Groundee. He who controls the spice, er, meds, controls the universe!